Rutin effectively ameliorated the expression of NF-κB inflammatory pathway members, including NF-κB, IκB kinase (IKK)-α, and IKK-β in HT29 colon cancer cells [19]. The gene discussed is NFKB1; the disease is malignant colon neoplasm.